Skip to main content
. 2021 Apr 30;9(5):496. doi: 10.3390/biomedicines9050496

Figure 2.

Figure 2

Prevalence of MCT8-aAb and MCT10-aAb in healthy control subjects. A cohort of healthy male and female subjects (n = 200 each) were tested in parallel for (A) MCT8-aAb, and (B) MCT10-aAb. Using the outlier criterion of the 75th percentile (P75) plus 1.5-times the inter quartile range (P75 + 1.5 × IQR), a prevalence of 3.8% for MCT8-aAb, and 4.5% for MCT10-aAb was observed. No sex-specific difference was noted. The binding index (y-axis, factor above background) and the thresholds for positivity (P75 + 1.5 × IQR of all signals, broken horizontal lines) are indicated.